Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 311

1.

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, Tew M, Zhang P, Ye W, Lizheng S, Herman W, McEwan P, Schramm W, Gray A, Leal J, Lamotte M, Willis M, Palmer AJ, Clarke P.

Pharmacoeconomics. 2019 Jul 26. doi: 10.1007/s40273-019-00825-1. [Epub ahead of print]

PMID:
31347104
2.

Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis.

Lau E, Salem A, Chan JCN, So WY, Kong A, Lamotte M, Luk A.

Cost Eff Resour Alloc. 2019 Jul 2;17:13. doi: 10.1186/s12962-019-0180-9. eCollection 2019.

3.

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.

Kotseva K, Gerlier L, Sidelnikov E, Kutikova L, Lamotte M, Amarenco P, Annemans L.

Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. doi: 10.1177/2047487319834770. Epub 2019 Apr 6.

PMID:
30955367
4.

Cost-effectiveness of physical activity in the management of COPD patients in the UK.

Ramos M, Lamotte M, Gerlier L, Svangren P, Miquel-Cases A, Haughney J.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239. doi: 10.2147/COPD.S181194. eCollection 2019.

5.

Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients.

Goodall G, Lamotte M, Ramos M, Maunoury F, Pejchalova B, de Pouvourville G.

J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018.1559600. Epub 2019 Feb 11.

PMID:
30547704
6.

Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach.

Foos V, Wang K, McEwan P, Zhang Y, Xin P, Jiang X, Qu S, Xiong T, De Moor R, Ramos M, Lamotte M, Ji L.

Value Health Reg Issues. 2019 May;18:36-46. doi: 10.1016/j.vhri.2018.08.006. Epub 2018 Nov 9.

PMID:
30419449
7.

The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden.

Bilir SP, Hellmund R, Wehler E, Li H, Munakata J, Lamotte M.

Eur Endocrinol. 2018 Sep;14(2):80-85. doi: 10.17925/EE.2018.14.2.80. Epub 2018 Sep 10. Review.

8.

Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden.

Bilir SP, Hellmund R, Wehler B, Li H, Munakata J, Lamotte M.

Eur Endocrinol. 2018 Sep;14(2):73-79. doi: 10.17925/EE.2018.14.2.73. Epub 2018 Sep 10. Review.

9.

Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico.

Rodríguez-Zepeda MDC, González L, Bravo A, Pompa T, Silva S, Paredes R, García J, Ramos M, Wilkinson L, Lamotte M.

Value Health Reg Issues. 2018 Dec;17:164-173. doi: 10.1016/j.vhri.2018.06.007. Epub 2018 Oct 12.

PMID:
30317158
10.

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O'Connor PJ, Brandle M, Smolen HJ, Gahn JC, Valentine WJ, Pollock RF, Breeze P, Brennan A, Pollard D, Ye W, Herman WH, Isaman DJ, Kuo S, Laiteerapong N, Tran-Duy A, Clarke PM.

Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9.

11.

Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group.

Hansen D, Niebauer J, Cornelissen V, Barna O, Neunhäuserer D, Stettler C, Tonoli C, Greco E, Fagard R, Coninx K, Vanhees L, Piepoli MF, Pedretti R, Ruiz GR, Corrà U, Schmid JP, Davos CH, Edelmann F, Abreu A, Rauch B, Ambrosetti M, Braga SS, Beckers P, Bussotti M, Faggiano P, Garcia-Porrero E, Kouidi E, Lamotte M, Reibis R, Spruit MA, Takken T, Vigorito C, Völler H, Doherty P, Dendale P.

Sports Med. 2018 Aug;48(8):1781-1797. doi: 10.1007/s40279-018-0930-4. Review.

12.

The epigenetic control of transposable elements and imprinted genes in newborns is affected by the mode of conception: ART versus spontaneous conception without underlying infertility.

Choux C, Binquet C, Carmignac V, Bruno C, Chapusot C, Barberet J, Lamotte M, Sagot P, Bourc'his D, Fauque P.

Hum Reprod. 2018 Feb 1;33(2):331-340. doi: 10.1093/humrep/dex366.

PMID:
29237055
13.

Atmospheric tritium concentrations under influence of AREVA NC La Hague reprocessing plant (France) and background levels.

Connan O, Hébert D, Solier L, Maro D, Pellerin G, Voiseux C, Lamotte M, Laguionie P.

J Environ Radioact. 2017 Oct;177:184-193. doi: 10.1016/j.jenvrad.2017.06.015. Epub 2017 Jul 6.

PMID:
28689161
14.

Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.

Decuypere F, Sermon J, Geerts P, Denee TR, De Vos C, Malfait B, Lamotte M, Mulder CL.

PLoS One. 2017 Jun 14;12(6):e0179049. doi: 10.1371/journal.pone.0179049. eCollection 2017.

15.

The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology.

Hansen D, Dendale P, Coninx K, Vanhees L, Piepoli MF, Niebauer J, Cornelissen V, Pedretti R, Geurts E, Ruiz GR, Corrà U, Schmid JP, Greco E, Davos CH, Edelmann F, Abreu A, Rauch B, Ambrosetti M, Braga SS, Barna O, Beckers P, Bussotti M, Fagard R, Faggiano P, Garcia-Porrero E, Kouidi E, Lamotte M, Neunhäuserer D, Reibis R, Spruit MA, Stettler C, Takken T, Tonoli C, Vigorito C, Völler H, Doherty P.

Eur J Prev Cardiol. 2017 Jul;24(10):1017-1031. doi: 10.1177/2047487317702042. Epub 2017 Apr 18. Review.

16.

Embryo multinucleation at the two-cell stage is an independent predictor of intracytoplasmic sperm injection outcomes.

Desch L, Bruno C, Luu M, Barberet J, Choux C, Lamotte M, Schmutz E, Sagot P, Fauque P.

Fertil Steril. 2017 Jan;107(1):97-103.e4. doi: 10.1016/j.fertnstert.2016.09.022. Epub 2016 Oct 26.

PMID:
28228320
17.

Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model.

Gerlier L, Lamotte M, Grenèche S, Lenne X, Carrat F, Weil-Olivier C, Damm O, Schwehm M, Eichner M.

Appl Health Econ Health Policy. 2017 Apr;15(2):261-276. doi: 10.1007/s40258-016-0296-4.

PMID:
27943165
18.

The VATO project: An original methodology to study the transfer of tritium as HT and HTO in grassland ecosystem.

Maro D, Vermorel F, Rozet M, Aulagnier C, Hébert D, Le Dizès S, Voiseux C, Solier L, Cossonnet C, Godinot C, Fiévet B, Laguionie P, Connan O, Cazimajou O, Morillon M, Lamotte M.

J Environ Radioact. 2017 Feb;167:235-248. doi: 10.1016/j.jenvrad.2016.10.016. Epub 2016 Nov 29.

PMID:
27908461
19.

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD.

Ramos M, Haughney J, Henry N, Lindner L, Lamotte M.

Clinicoecon Outcomes Res. 2016 Sep 12;8:445-56. doi: 10.2147/CEOR.S107121. eCollection 2016.

20.

Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.

Gerlier L, Lamotte M, Dos Santos Mendes S, Damm O, Schwehm M, Eichner M.

Paediatr Drugs. 2016 Aug;18(4):303-18. doi: 10.1007/s40272-016-0180-6.

PMID:
27272706

Supplemental Content

Loading ...
Support Center